1 completed, 1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Receptor, Endothelin A: new trials by email Literature Review of Receptor, Endothelin A trials Research Report on Receptor, Endothelin A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients Tofacitinib, Etanercept - Rheumatic Arthritis | Phase 4 | Completed | Dr. Frank Behrens | 92 | 2019-11-04 | 2024-08-28 |
| Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers Eligibility and lifestyle restrictions check., Medical history, demographic and lifestyle factors, Anthropometric measurements: height, weight, and body fat - Cardiovascular Diseases | Terminated | Cambridge University Hospitals NHS Foundation Trust | 74 | 2017-08-14 | 2024-02-02 |
Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Hypertension (1) · Non-alcoholic Fatty Liver Disease (1) · Pain (1) · Rheumatic Fever (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Cambridge University Hospitals NHS Foundation Trust (1) · Dr. Frank Behrens (1)
Germany (1) · United Kingdom (1)
Dirk Paul, PhD (1) · Harald Burkhardt, MD (1)